Call Options

24 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$53.58 - $57.02 $7.24 Million - $7.71 Million
-135,200 Reduced 63.06%
79,200 $4.45 Million
Q1 2024

May 07, 2024

SELL
$42.56 - $59.82 $3.56 Million - $5 Million
-83,600 Reduced 28.05%
214,400 $12.1 Million
Q4 2023

Feb 14, 2024

SELL
$32.18 - $46.57 $10.7 Million - $15.5 Million
-333,700 Reduced 52.83%
298,000 $13.4 Million
Q3 2023

Nov 14, 2023

BUY
$44.2 - $50.2 $11.2 Million - $12.7 Million
252,300 Added 66.5%
631,700 $28.8 Million
Q2 2023

Aug 11, 2023

BUY
$31.86 - $67.26 $8.89 Million - $18.8 Million
279,000 Added 277.89%
379,400 $16.5 Million
Q1 2023

May 16, 2023

BUY
$45.44 - $74.26 $3.14 Million - $5.12 Million
69,000 Added 219.75%
100,400 $6.6 Million
Q4 2022

Feb 14, 2023

SELL
$41.39 - $81.0 $3.96 Million - $7.74 Million
-95,600 Reduced 75.28%
31,400 $1.41 Million
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $730,836 - $1.14 Million
10,100 Added 8.64%
127,000 $9.19 Million
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $3.66 Million - $4.79 Million
-42,000 Reduced 26.43%
116,900 $12.5 Million
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $10 Million - $13.2 Million
106,400 Added 202.67%
158,900 $17.6 Million
Q4 2021

Feb 14, 2022

SELL
$119.57 - $139.07 $1.41 Million - $1.64 Million
-11,800 Reduced 18.35%
52,500 $6.72 Million
Q3 2021

Nov 15, 2021

BUY
$109.17 - $142.35 $2.95 Million - $3.84 Million
27,000 Added 72.39%
64,300 $8.56 Million
Q2 2021

Aug 11, 2021

SELL
$100.34 - $115.69 $1.44 Million - $1.67 Million
-14,400 Reduced 27.85%
37,300 $4.03 Million
Q1 2021

May 17, 2021

SELL
$101.51 - $125.27 $9.16 Million - $11.3 Million
-90,200 Reduced 63.57%
51,700 $5.45 Million
Q4 2020

Feb 16, 2021

BUY
$85.88 - $105.36 $377,872 - $463,584
4,400 Added 3.2%
141,900 $14.8 Million
Q3 2020

Nov 16, 2020

BUY
$72.74 - $92.5 $4.5 Million - $5.72 Million
61,800 Added 81.64%
137,500 $11.8 Million
Q2 2020

Aug 14, 2020

BUY
$48.02 - $79.04 $1.18 Million - $1.94 Million
24,600 Added 48.14%
75,700 $5.55 Million
Q1 2020

May 15, 2020

SELL
$36.95 - $62.95 $812,900 - $1.38 Million
-22,000 Reduced 30.1%
51,100 $2.66 Million
Q4 2019

Feb 14, 2020

SELL
$47.06 - $56.64 $371,774 - $447,456
-7,900 Reduced 9.75%
73,100 $4.12 Million
Q3 2019

Nov 14, 2019

BUY
$47.45 - $58.05 $1.48 Million - $1.81 Million
31,200 Added 62.65%
81,000 $3.86 Million
Q2 2019

Aug 14, 2019

SELL
$39.26 - $54.21 $1.65 Million - $2.28 Million
-42,100 Reduced 45.81%
49,800 $2.7 Million
Q1 2019

May 15, 2019

BUY
$29.84 - $43.92 $2.25 Million - $3.31 Million
75,400 Added 456.97%
91,900 $3.73 Million
Q4 2018

Feb 14, 2019

BUY
$29.95 - $46.34 $260,565 - $403,158
8,700 Added 111.54%
16,500 $514,000
Q1 2018

May 15, 2018

BUY
$39.4 - $47.39 $307,320 - $369,642
7,800 New
7,800 $320,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.8B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.